Apoptosis-related genes and proteins in Hodgkin's disease

APMIS

Volumn 107, Issue 7, 1999, Pages 636-644

  Lauritzen, Anne F ^a,c   Møller, Peter Horn ^a   Nedergaard, Trine ^b   Guldberg, Per ^b   Hou Jensen, Klaus ^a   Ralfkiaer, Elisabeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

Author keywords

B cells; Bax; Bcl 2; Bcl x; Epstein Barr virus; Hodgkin's disease; p53

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; EPSTEIN BARR VIRUS; GENOTYPE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REED STERNBERG CELL; SEQUENCE ANALYSIS;

EID: 0032782683     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01453.x     Document Type: Article

References (60)

1. 1. Harris NL, Jaffe E, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
2. 2. Isaacson P, Ashton-Key M. Phenotype of Hodgkin and Reed-Sternberg cells. Lancet 1996;347: 481.
3. 3. Marafioti T, Hummel M, Anagnostopoulos I, Foss H-D, Falini B, Delsol G, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997; 337:453-8.
4. 4. Mason DY, Banks P, Chan J, Cleary M, Delsol G, Wolf-Peters D, et al. Nodular lymphocyte-predominance Hodgkin's disease. A distinct clinico-pathological entity. Am J Surg Pathol 1994; 18:526-30.
5. 5. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992;8:283-313.
6. 6. Herbst H, Raff T, Stein H. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol 1996;179:54-9.
7. 7. Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, et al. Distribution and phenotype of Epstein-Barr virus-harbouring cells in Hodgkin's disease. Blood 1992; 80:484-91.
8. 8. Lauritzen AF, Hørding U, Nielsen HW. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridisation, and polymerase chain reaction study. APMIS 1994;102: 495-500.
9. 9. Teerenhovi L, Lindblom C, Pakkala A, Franssila K, Stein H, Knuutila S. Unique display of a pathologic karyotype in Hodgkin's disease by Reed-Sternberg cells. Cancer Genet Cytogenet 1988;34:305-11.
10. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86:1464-8.
11. 11. Rigal-Huguet F, Gopas J, Prinsloo I, Pris J, Delsol G, Reed JC, et al. Frequent expression of the cell-death inducing gene bax in Reed-Sternberg cells of Hodgkin's disease. Blood 1996; 87:2470-5.
12. 12. Chen W-G, Chen Y-Y, Kamel OW, Koo CH, Weiss, L. P53 mutations in Hodgkin's disease. Lab Invest 1996;75:519-27.
13. 13. Lorenzen J, Hansmann M-L, Pezella F, Hesse C, Kneba M, Gatter K, et al. Expression of bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. Hum Pathol 1992;23:1205-9.
14. 14. Schlaifer D, Krajewski S, Rigal-Huguet F, Laurent G, Pris J, Delsol G, et al. Bcl-x gene expression in Hodgkin's disease. Leuk Lymphoma 1996; 23:143-6.
15. 15. Schlaifer D, March M, Kajewski S, Laurent G, Pris J, Delsol G, et al. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 1995;85:2671-4.
16. 16. Stetler-Stevenson M, Crush-Stanton S, Cossman J. Involvement of the bcl-2 gene in Hodgkin's disease. J Natl Cancer Inst 1990;82:855-8.
17. 17. Trümper LH, Brady G, Bagg A, Gray D, Loke SL, Griesser H, et al. Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations. Blood 1993;81:3097-115.
18. 18. Hørding U, Nielsen HW, Albeck H, Daugaard, S. Nasopharyngeal carcinoma: histopathological types and association with Epstein-Barr virus. Eur J Cancer B Oral Oncol 1993;29B:137-9.
19. 19. Sambrook J, Fritsch EF, Maniatis T. In: Nolan C, editor. Molecular Cloning: A laboratory manual, Second edition: Cold Spring Habor Laboratory Press; 1989.
20. 20. Hoppe BL, Conti-Tronconi BM, Horton RM. Gel-loading dyes compatible with PCR. BioTechniques 1992;12:679-80.
21. 21. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1988;85:4869-73.
22. 22. Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol 1995;103:472-8.
23. 23. Klefstrom J, Franssila K, Peltomaki P, Kaartinen M, Solin ML, Knuutila S. Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas. Leuk Res 1994;18:245-50.
24. 24. Huang X. On global sequence alignment. Comput Appl Biosci 1994;10:227-35.
25. 25. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986;83:5214-8.
26. 26. Tomlinson IM, Williams SC, Corbett SJ, Cox JLP, Winter G. MRC Centre for Protein Engineering: The V Base Database at http://www.mrc. mrc-cpe.cam.ac.uk/imt-doc/public/INTRO.htlm
27. 27. Guldberg P, Nedergaard T, Nielsen HJ, Olsen AC, Ahrenkiel V, Zeuthen J. Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat 1997;9:348-55.
28. 28. Lauritzen AF, Hou-Jensen K, Ralfkiaer E. P53 protein expression in Hodgkin's disease. APMIS 1993;101:689-94.
29. 29. Hall PA, D'Ardenne AJ, Stansfeld AG. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Kil) lymphoma. Histopathology 1988;13;161-9.
30. 30. Lauritzen AF, Ralfkiaer E. Use of monoclonal antibodies for the typing of malignant lymphomas in routinely processed biopsy samples. APMIS 1991;99:631-9.
31. 31. Norton AJ, Isaacson PG. Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues: II. Profiles of reactivity in the various tumour types. Histopathology 1989;14: 557-79.
32. 32. Cibull ML, Stein H, Gatter KC, Mason DY. The expression of the CD3 antigen in Hodgkin's disease. Histopathology 1989;15:597-605.
33. 33. Korkolopoulou P, Cordell J, Jones M, Kaklamanis L, Tsenga A, Gatter K, et al. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 1994;24:511-5.
34. 34. Kuzu I, Delsol G, Jones M, Gatter K, Mason DY. Expression of the Ig-associated heterodimer (mb-1 and B29) in Hodgkin's disease. Histopathology 1993:22:141-4.
35. 35. Schmid C, Pan L, Diss T, Isaacson PG. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 1991;139:701-7.
36. 36. Delabie J, Tierens A, Wu G, Weisenburger DD, Chan WC. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994;84:3291-8.
37. 37. Hummel M, Zieman K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 1995;333:901-5.
38. 38. Küppers R, Rajewsky K, Zhao M, Simons G, Lauman R, Fischer R, et al. Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show immunoglobulin gene rearrangements and appear to be derived from B-cells at various stages of development. Proc Natl Acad Sci USA 1994;91:10962-6.
39. 39. Delsol G, Megetto F, Brousset P, Cohen-Knafo E, Al Saati E, Rochaix P, et al. Relation of follicular dendritic cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am J Pathol 1993;142: 1729-38.
40. 40. Raimond I, Al Saati T, Tkaczuk J, Chittal S, Delsol G. CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells. Am J Pathol 1997;151:1577-85.
41. 41. Kanzler H, Küppers R., Hansmann M-L, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996;184: 1495-505.
42. H genes. Blood 1994;3:708-15.
43. 43. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993;74:609-19.
44. 44. Boise LH, Gonzales-Garzia M, Postema CE, Ding L, Lindsten T, Turka LA, et al. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597-608.
45. 45. Doussis IA, Pezzella F, Lane DP, Gatter KC, Mason D. An immunocytochemical study of p53 and bcl-2 protein in Hodgkin's disease. Am J Clin Pathol 1993;99:663-7.
46. 46. Messineo C, Jamerson MH, Hunter E, Braziel R, Bagg A, Irving SG, et al. Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation. Blood 1998;91:2443-51.
47. 47. Athan E, Chadburn A, Knowles DM. The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridisation and polymerase chain reaction. Am J Pathol 1992; 141:193-201.
48. 48. Gravel S, Delsol G, Al Saati T. Single-cell analysis of the t(14;18)(q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells. Blood 1998;91:2866-74.
49. 49. Corbally N, Grogan L, Keane MM, Devaney DM, Dervan PA, Carney DN. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes. Am J Clin Pathol 1994;101:756-60.
50. 50. Limpens J, de Jong D, Van-Krieken JH, Price CAG, Young BD, van Ommen G-JB, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6: 2271-6.
51. 51. Monni O, Joenssu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S. Bcl-2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 1997;90:1168-74.
52. 52. Werner CA, Döhner H, Joos S, Trümper LH, Baudis M, Barth TF, et al. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol 1997;151:335-42.
53. 53. Finke J, Fritzen R, Ternes P, Bross KM, Lange W, Mertelsmann R, et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992;80:459-69.
54. 54. Bhagat SKM, Medeiros LJ, Weiss LM, Wang JW, Raffeld M, Stetler-Stevenson M. Bcl-2 expression in Hodgkin's disease. Correlation with t(14;18) translocation and Epstein-Barr virus. Am J Clin Pathol 1993;99:604-8.
55. 55. Tao Q, Srivastava G, Loke SL, Ho FSC. Lack of correlation between expression of Epstein-Barr virus (EBV) latent membrane protein and bcl-2 oncoprotein in vivo. J Clin Pathol 1994;47:589-91.
56. 56. Elinotopa-Johnson KSJ, Medeiros J, Khorsand J, King TC. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease. Am J Clin Pathol 1996; 106:728-38.
57. 57. Gupta RK, Norton AJ, Thompson IW, Lister TA, Bodmer JG. P53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J Cancer 1992;66:649-52.
58. 58. Lorenzen J, Thiele J, Fischer R. The mummified Hodgkin cell: cell death in Hodgkin's disease. J Pathol 1997;182:288-98.
59. WAF1/CIP1, wild type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease. J Pathol 1996;180:58-64.
60. WAF1/CIP1/SDI1. Oncogene 1995;11:1409-15.